theophylline has been researched along with Tremor in 36 studies
Tremor: Cyclical movement of a body part that can represent either a physiologic process or a manifestation of disease. Intention or action tremor, a common manifestation of CEREBELLAR DISEASES, is aggravated by movement. In contrast, resting tremor is maximal when there is no attempt at voluntary movement, and occurs as a relatively frequent manifestation of PARKINSON DISEASE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Propranolol, which has long been used as the standard treatment for essential tremor, has been compared with placebo and theophylline in ten newly diagnosed patients without other, prior drug treatments." | 9.08 | Efficacy of an adenosine antagonist, theophylline, in essential tremor: comparison with placebo and propranolol. ( Mally, J; Stone, TW, 1995) |
| "To determine whether controlled-release theophylline inhibits the development of airway obstruction and/or airway hyperresponsiveness early in the morning, we examined 18 subjects reporting recurrent nocturnal asthma." | 9.08 | Controlled-release theophylline inhibits early morning airway obstruction and hyperresponsiveness in asthmatic subjects. ( Boschetto, P; Crescioli, S; Dal Carobbo, A; Fabbri, LM; Hurst, TS; Maestrelli, P; Parise, G; Santagada, T; Steinijans, VW, 1996) |
| "The effects of intravenous aminophylline (375 mg) or placebo (saline) were studied in 10 patients with benign essential tremor." | 9.08 | The effect of intravenous aminophylline on essential tremor. ( Buss, DC; Compston, DA; Marshall, RW; McQueen, I; Milligan, N; Routledge, PA, 1997) |
| "The chronic administration of theophylline was studied in twenty patients with essential tremor in a double-blind cross-over trial." | 9.07 | The effect of theophylline on essential tremor: the possible role of GABA. ( Mally, J; Stone, TW, 1991) |
| "Propranolol having been used for decades was compared with low dose theophylline and placebo in the treatment of essential tremor." | 9.07 | [Comparative study of theophylline and propranolol in essential tremor]. ( Málly, J, 1992) |
| "In a group of ten patients with chronic asthmatic bronchitis, the effect of monotherapy with theophylline and terbutaline and the combination of both drugs, as sustained-release tablets, was compared to placebo, in a double-blind cross-over, triple dummy at random study." | 9.06 | Combination therapy of theophylline and terbutaline as sustained-release preparations in patients with asthmatic bronchitis. ( Fokkens, JK; Hamelink, MJ; Kreukniet, J; Maes, RA; van der Vet, AP; van Drost, RH, 1987) |
| " The effect of intravenous aminophylline on theophylline-induced tremor were studied in six hyperthyroid patients before and after treatment to euthyroidism." | 9.06 | The effect of theophylline on thyrotoxic tremor. ( Buss, DC; Lazarus, JH; Littley, MD; Marshall, RW; Phillips, DI; Routledge, PA, 1989) |
| "After one week theophylline therapy with a sustained release preparation (TheoDur 200 and 300 mg), a mean theophylline level of 10 mg/l was obtained in a group of ten patients with chronic asthmatic bronchitis with a mean dosage of 760 mg theophylline/24 h." | 9.06 | Lung function improvement, tremor measurements and c-AMP determinations in a group of ten patients with asthmatic bronchitis after one week sustained release theophylline medication (theophylline plasma level +/- 10 mg/l) compared to one week placebo. ( Drost, RH; Fokkens, JK; Hamelink, ML; Kreukniet, J; Maes, RA; Van der Vet, AP, 1986) |
| "5 mg) combined with 280 mg anhydrous theophylline orally in the randomized, double-blind, cross-over study in eight asthmatics." | 9.05 | Effects of oral theophylline combined with oral and inhaled beta-2-adrenostimulants in asthmatics. ( Svedmyr, K, 1982) |
| "Bronchodilation and side effects of 28 days treatment with either a full therapeutic dose of theophylline slow-release preparation 500 mg twice daily (400-600 mg), a slow-release terbutaline preparation 10 mg twice daily or combinations of the 2 drugs in full or half doses were evaluated in 31 asthmatic outpatients in a double-blind, randomized crossover design." | 9.05 | Long-term oral therapy of asthma with terbutaline and theophylline, alone and combined. ( Gnosspelius, Y; Gymose, E; Laursen, LC; Taudorf, E; Weeke, B, 1985) |
| "The bioavailability of three different theophylline tablets (microcrystallinic theophylline, Theolair, Nuelin, 3M Riker), choline theophyllinate as a new film-coated tablet (Teovent, Ferrosan, Sweden) and theophyllaminopropanol (Oxyphylline, Draco, Sweden) was investigated in eight adult asthmatics and a randomized, double-blind, cross-over study." | 9.05 | Bioavailability of theophylline from three different tablets in asthmatic patients and their bronchodilating effects in combination with terbutaline inhalation. ( Mellstrand, T; Svedmyr, K; Svedmyr, N, 1982) |
| "A double-blind crossover trial was conducted in 10 asthmatic patients for comparison of fenoterol with salbutamol, in 12 other asthmatic patients for comparison of reproterol with salbutamol, and in 15 other asthmatic patients for comparison of terbutaline with salbutamol." | 9.04 | [The bronchospasmolytics salbutamol, fenoterol, terbutaline and reproterol. Their effects and side effects in asthmatics after inhalation with an electric nebulizer]. ( Budmiger, H; Kyd, K; Scherrer, M, 1978) |
| "Theophylline concentrations in saliva and serum were compared in 20 patients with essential tremor." | 7.68 | Theophylline concentrations in serum, saliva, and cerebrospinal fluid in patients with essential tremor. ( Cserep, G; Keszei, C; Mally, J, 1992) |
| "A group of 10 patients with chronic asthmatic bronchitis was titrated with slow-release theophylline (Theolin Retard) to a steady state plasma theophylline level of 10 mg/l." | 7.67 | Pharmacodynamics (lung function tests, tremor measurements and cAMP determinations) of a single dose of 0.5 mg terbutaline subcutaneously during sustained-release theophylline medication in patients with asthmatic bronchitis. ( Drost, RH; Fokkens, JK; Hamelink, ML; Kreukniet, J; Maes, RA; van der Vet, AP, 1986) |
| "The bronchodilating properties and side effects of theophylline and a beta 2-adrenoceptor stimulating drug (terbutaline) alone and in combination were studied in 10 adult asthmatic patients." | 7.66 | Separate and combined use of terbutaline and theophylline in asthmatics. Effects related to plasma levels. ( Billing, B; Dahlqvist, R; Garle, M; Hörnblad, Y; Ripe, E, 1982) |
| "Adenosine is a major modulator of neuronal activity and neurotransmitter release in the central nervous system, with A1 receptors inhibiting transmitter release and A2 receptors generally enhancing release of several transmitter systems relevant to the control of movement." | 6.39 | Potential role of adenosine antagonist therapy in pathological tremor disorders. ( Mally, J; Stone, TW, 1996) |
| "The effects of intravenous aminophylline (375 mg) or placebo (saline) were studied in 10 patients with benign essential tremor." | 5.08 | The effect of intravenous aminophylline on essential tremor. ( Buss, DC; Compston, DA; Marshall, RW; McQueen, I; Milligan, N; Routledge, PA, 1997) |
| "Propranolol, which has long been used as the standard treatment for essential tremor, has been compared with placebo and theophylline in ten newly diagnosed patients without other, prior drug treatments." | 5.08 | Efficacy of an adenosine antagonist, theophylline, in essential tremor: comparison with placebo and propranolol. ( Mally, J; Stone, TW, 1995) |
| "To determine whether controlled-release theophylline inhibits the development of airway obstruction and/or airway hyperresponsiveness early in the morning, we examined 18 subjects reporting recurrent nocturnal asthma." | 5.08 | Controlled-release theophylline inhibits early morning airway obstruction and hyperresponsiveness in asthmatic subjects. ( Boschetto, P; Crescioli, S; Dal Carobbo, A; Fabbri, LM; Hurst, TS; Maestrelli, P; Parise, G; Santagada, T; Steinijans, VW, 1996) |
| "Propranolol having been used for decades was compared with low dose theophylline and placebo in the treatment of essential tremor." | 5.07 | [Comparative study of theophylline and propranolol in essential tremor]. ( Málly, J, 1992) |
| "The chronic administration of theophylline was studied in twenty patients with essential tremor in a double-blind cross-over trial." | 5.07 | The effect of theophylline on essential tremor: the possible role of GABA. ( Mally, J; Stone, TW, 1991) |
| " The effect of intravenous aminophylline on theophylline-induced tremor were studied in six hyperthyroid patients before and after treatment to euthyroidism." | 5.06 | The effect of theophylline on thyrotoxic tremor. ( Buss, DC; Lazarus, JH; Littley, MD; Marshall, RW; Phillips, DI; Routledge, PA, 1989) |
| "In a group of ten patients with chronic asthmatic bronchitis, the effect of monotherapy with theophylline and terbutaline and the combination of both drugs, as sustained-release tablets, was compared to placebo, in a double-blind cross-over, triple dummy at random study." | 5.06 | Combination therapy of theophylline and terbutaline as sustained-release preparations in patients with asthmatic bronchitis. ( Fokkens, JK; Hamelink, MJ; Kreukniet, J; Maes, RA; van der Vet, AP; van Drost, RH, 1987) |
| "After one week theophylline therapy with a sustained release preparation (TheoDur 200 and 300 mg), a mean theophylline level of 10 mg/l was obtained in a group of ten patients with chronic asthmatic bronchitis with a mean dosage of 760 mg theophylline/24 h." | 5.06 | Lung function improvement, tremor measurements and c-AMP determinations in a group of ten patients with asthmatic bronchitis after one week sustained release theophylline medication (theophylline plasma level +/- 10 mg/l) compared to one week placebo. ( Drost, RH; Fokkens, JK; Hamelink, ML; Kreukniet, J; Maes, RA; Van der Vet, AP, 1986) |
| "5 mg) combined with 280 mg anhydrous theophylline orally in the randomized, double-blind, cross-over study in eight asthmatics." | 5.05 | Effects of oral theophylline combined with oral and inhaled beta-2-adrenostimulants in asthmatics. ( Svedmyr, K, 1982) |
| "The bioavailability of three different theophylline tablets (microcrystallinic theophylline, Theolair, Nuelin, 3M Riker), choline theophyllinate as a new film-coated tablet (Teovent, Ferrosan, Sweden) and theophyllaminopropanol (Oxyphylline, Draco, Sweden) was investigated in eight adult asthmatics and a randomized, double-blind, cross-over study." | 5.05 | Bioavailability of theophylline from three different tablets in asthmatic patients and their bronchodilating effects in combination with terbutaline inhalation. ( Mellstrand, T; Svedmyr, K; Svedmyr, N, 1982) |
| "Bronchodilation and side effects of 28 days treatment with either a full therapeutic dose of theophylline slow-release preparation 500 mg twice daily (400-600 mg), a slow-release terbutaline preparation 10 mg twice daily or combinations of the 2 drugs in full or half doses were evaluated in 31 asthmatic outpatients in a double-blind, randomized crossover design." | 5.05 | Long-term oral therapy of asthma with terbutaline and theophylline, alone and combined. ( Gnosspelius, Y; Gymose, E; Laursen, LC; Taudorf, E; Weeke, B, 1985) |
| "The influence of pretreatment with equipment bronchodilating doses of intravenous theophyllamine and inhaled terbutaline on the effect of five terbutaline inhalations was investigated in a cross-over study in six adult asthmatics with stable and reproducible bronchoconstriction." | 5.05 | Does theophylline potentiate inhaled beta 2-agonists? ( Svedmyr, K; Svedmyr, N, 1982) |
| "A double-blind crossover trial was conducted in 10 asthmatic patients for comparison of fenoterol with salbutamol, in 12 other asthmatic patients for comparison of reproterol with salbutamol, and in 15 other asthmatic patients for comparison of terbutaline with salbutamol." | 5.04 | [The bronchospasmolytics salbutamol, fenoterol, terbutaline and reproterol. Their effects and side effects in asthmatics after inhalation with an electric nebulizer]. ( Budmiger, H; Kyd, K; Scherrer, M, 1978) |
| "In a single-blind, crossover study 10 adult asthmatic patients received a theophylline-ephedrine combination tablet (theophylline 90 mg, ephedrine 16 mg and phenobarbital 25 mg in an immediate release layer and theophylline 90 mg and ephedrine 32 mg in a sustained release layer) twice daily or terbutaline 5 mg three times daily for two weeks." | 5.04 | A comparison of a theophylline-ephedrine combination with terbutaline. ( Alcala, JC; Bush, RK; Lee, TP; Smith, AM; Welling, PG, 1978) |
| "Theophylline concentrations in saliva and serum were compared in 20 patients with essential tremor." | 3.68 | Theophylline concentrations in serum, saliva, and cerebrospinal fluid in patients with essential tremor. ( Cserep, G; Keszei, C; Mally, J, 1992) |
| "The bronchodilating effect and side-effects of theophylline and a beta 2-adrenoceptor stimulating drug (terbutaline) alone and in combination were studied in 10 adult asthmatic patients." | 3.67 | Simultaneous treatment with terbutaline and theophylline. ( Billing, B; Dahlqvist, R; Garle, M; Hörnblad, Y; Ripe, E, 1984) |
| "A group of 10 patients with chronic asthmatic bronchitis was titrated with slow-release theophylline (Theolin Retard) to a steady state plasma theophylline level of 10 mg/l." | 3.67 | Pharmacodynamics (lung function tests, tremor measurements and cAMP determinations) of a single dose of 0.5 mg terbutaline subcutaneously during sustained-release theophylline medication in patients with asthmatic bronchitis. ( Drost, RH; Fokkens, JK; Hamelink, ML; Kreukniet, J; Maes, RA; van der Vet, AP, 1986) |
| "The bronchodilating properties and side effects of theophylline and a beta 2-adrenoceptor stimulating drug (terbutaline) alone and in combination were studied in 10 adult asthmatic patients." | 3.66 | Separate and combined use of terbutaline and theophylline in asthmatics. Effects related to plasma levels. ( Billing, B; Dahlqvist, R; Garle, M; Hörnblad, Y; Ripe, E, 1982) |
| " No significant changes in other theophylline pharmacokinetic parameters were evident." | 2.69 | Lack of effect of dirithromycin on theophylline pharmacokinetics in healthy volunteers. ( Amsden, GW; McConnell, SA; Nafziger, AN, 1999) |
| " We found no evidence of a pharmacokinetic interaction between theophylline and erythromycin at steady state." | 2.65 | The effect of erythromycin on theophylline pharmacokinetics at steady state. ( Bauman, JL; Hasegawa, GR; Leeds, NH; Maddux, MS; Organek, HW, 1982) |
| " Neither at the low nor at the high dosage (2 +/- 4 mg/kg), giving plasma concentrations of 8." | 2.65 | Effects of enprofylline, a xanthine lacking adenosine receptor antagonism, in patients with chronic obstructive lung disease. ( Andersson, KE; Lunell, E; Persson, CG; Svedmyr, N, 1982) |
| "Drug-induced tremor is an important differential diagnosis for tremor syndromes." | 2.47 | [Drug-induced tremor]. ( Block, F; Dafotakis, M, 2011) |
| "The prognosis of Parkinson's disease presenting with tremor is better when presenting with hypokinesia." | 2.39 | [Most frequent causes for hand tremor in clinical practice]. ( Málly, J, 1995) |
| "Adenosine is a major modulator of neuronal activity and neurotransmitter release in the central nervous system, with A1 receptors inhibiting transmitter release and A2 receptors generally enhancing release of several transmitter systems relevant to the control of movement." | 2.39 | Potential role of adenosine antagonist therapy in pathological tremor disorders. ( Mally, J; Stone, TW, 1996) |
| "Physiologic postural skeletal muscle tremor is enhanced by beta 2 receptor agonist such as those used in the treatment of asthma." | 2.38 | Skeletal muscle tremor and the influence of adrenergic drugs. ( Ahrens, RC, 1990) |
| " Dosing errors accounted for the majority of cases." | 1.27 | Theophylline toxicity in children. ( Baker, MD, 1986) |
| "The bronchospasmolytic action of proxyphylline given intravenously in a dosage of 16 mg/kg body weight was assessed by spirometry and bodyplethysmography in 12 patients with chronic obstructive pulmonary disease." | 1.26 | [Effectiveness of proxyphylline in chronic obstructive pulmonary disease (author's transl)]. ( Förster, OB; Geisler, LS; Rohner, HG; Thiel, H, 1980) |
| " Comparison of bioavailability and absorption characteristics suggest usefulness of some of these products for the purpose of maintaining safe and effective blood levels with twice-a-day dosing." | 1.26 | Theophylline bioavailability following oral administration of six sustained-release preparations. ( Bloom, FL; Kalof, DD; Spangler, DL; Wittig, HJ, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (58.33) | 18.7374 |
| 1990's | 12 (33.33) | 18.2507 |
| 2000's | 1 (2.78) | 29.6817 |
| 2010's | 2 (5.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Trevitt, J | 1 |
| Kawa, K | 1 |
| Jalali, A | 1 |
| Larsen, C | 1 |
| Struble, LM | 1 |
| Block, F | 1 |
| Dafotakis, M | 1 |
| Svedmyr, K | 3 |
| Svedmyr, N | 3 |
| Galant, SP | 1 |
| Lunell, E | 1 |
| Andersson, KE | 1 |
| Persson, CG | 1 |
| Laursen, LC | 2 |
| Johannesson, N | 1 |
| Søndergaard, I | 1 |
| Weeke, B | 2 |
| Billing, B | 2 |
| Dahlqvist, R | 2 |
| Garle, M | 2 |
| Hörnblad, Y | 2 |
| Ripe, E | 2 |
| Shapiro, GG | 1 |
| McPhillips, JJ | 1 |
| Smith, K | 1 |
| Furukawa, CT | 1 |
| Pierson, WE | 1 |
| Bierman, CW | 1 |
| Maddux, MS | 1 |
| Leeds, NH | 1 |
| Organek, HW | 1 |
| Hasegawa, GR | 1 |
| Bauman, JL | 1 |
| Mellstrand, T | 1 |
| Geisler, LS | 1 |
| Thiel, H | 1 |
| Förster, OB | 1 |
| Rohner, HG | 1 |
| Málly, J | 6 |
| Bartel, PR | 1 |
| Ubbink, JB | 1 |
| Delport, R | 1 |
| Lotz, BP | 1 |
| Becker, PJ | 1 |
| Stone, TW | 3 |
| Crescioli, S | 1 |
| Dal Carobbo, A | 1 |
| Maestrelli, P | 1 |
| Boschetto, P | 1 |
| Santagada, T | 1 |
| Steinijans, VW | 1 |
| Hurst, TS | 1 |
| Parise, G | 1 |
| Fabbri, LM | 1 |
| Buss, DC | 2 |
| Marshall, RW | 2 |
| Milligan, N | 1 |
| McQueen, I | 1 |
| Compston, DA | 1 |
| Routledge, PA | 2 |
| McConnell, SA | 1 |
| Nafziger, AN | 1 |
| Amsden, GW | 1 |
| Bush, RK | 1 |
| Smith, AM | 1 |
| Welling, PG | 1 |
| Alcala, JC | 1 |
| Lee, TP | 1 |
| Spangler, DL | 1 |
| Kalof, DD | 1 |
| Bloom, FL | 1 |
| Wittig, HJ | 1 |
| Budmiger, H | 1 |
| Kyd, K | 1 |
| Scherrer, M | 1 |
| Stuart, AM | 1 |
| Worley, LM | 1 |
| Spillane, J | 1 |
| Keszei, C | 1 |
| Cserep, G | 1 |
| Ahrens, RC | 1 |
| Taudorf, E | 1 |
| Gnosspelius, Y | 1 |
| Gymose, E | 1 |
| Phillips, DI | 1 |
| Littley, MD | 1 |
| Lazarus, JH | 1 |
| van der Vet, AP | 3 |
| Kreukniet, J | 3 |
| van Drost, RH | 1 |
| Maes, RA | 3 |
| Fokkens, JK | 3 |
| Hamelink, MJ | 1 |
| Drost, RH | 2 |
| Hamelink, ML | 2 |
| Baker, MD | 1 |
| Chibanguza, G | 1 |
6 reviews available for theophylline and Tremor
| Article | Year |
|---|---|
Tremors: learning to stop the shakes.
Topics: Adrenergic beta-Antagonists; Alprazolam; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Gabap | 2010 |
[Drug-induced tremor].
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Antagonists; Animals; Anticonvulsants; Antidepr | 2011 |
Current status of beta-adrenergic agonists in bronchial asthma.
Topics: Adrenergic beta-Agonists; Asthma; Bronchodilator Agents; Child; Drug Synergism; Drug Tolerance; Huma | 1983 |
[Most frequent causes for hand tremor in clinical practice].
Topics: Aged; Aged, 80 and over; Aging; Female; Hand; Humans; Hypokinesia; Male; Parkinson Disease; Posture; | 1995 |
Potential role of adenosine antagonist therapy in pathological tremor disorders.
Topics: Adenosine; Adrenergic Antagonists; Brain; Corpus Striatum; Humans; Motor Activity; Motor Skills; Rec | 1996 |
Skeletal muscle tremor and the influence of adrenergic drugs.
Topics: Adrenergic beta-Agonists; Biomechanical Phenomena; Drug Synergism; Drug Tolerance; Humans; Self Conc | 1990 |
20 trials available for theophylline and Tremor
| Article | Year |
|---|---|
Does theophylline potentiate inhaled beta 2-agonists?
Topics: Administration, Intranasal; Administration, Oral; Adrenergic beta-Agonists; Asthma; Blood Pressure; | 1982 |
Effects of oral theophylline combined with oral and inhaled beta-2-adrenostimulants in asthmatics.
Topics: Administration, Intranasal; Administration, Oral; Adrenergic beta-Agonists; Adult; Aged; Asthma; Blo | 1982 |
Effects of enprofylline, a xanthine lacking adenosine receptor antagonism, in patients with chronic obstructive lung disease.
Topics: Adult; Aged; Clinical Trials as Topic; Female; Forced Expiratory Volume; Hemodynamics; Humans; Lung | 1982 |
Maximally effective plasma concentrations of enprofylline and theophylline during constant infusion.
Topics: Adult; Aged; Bronchodilator Agents; Female; Forced Expiratory Volume; Humans; Infusions, Parenteral; | 1984 |
Effectiveness of terbutaline and theophylline alone and in combination in exercise-induced bronchospasm.
Topics: Adolescent; Adult; Asthma; Asthma, Exercise-Induced; Child; Clinical Trials as Topic; Double-Blind M | 1981 |
The effect of erythromycin on theophylline pharmacokinetics at steady state.
Topics: Administration, Oral; Adult; Clinical Trials as Topic; Erythromycin; Female; Headache; Humans; Kinet | 1982 |
Bioavailability of theophylline from three different tablets in asthmatic patients and their bronchodilating effects in combination with terbutaline inhalation.
Topics: Administration, Intranasal; Administration, Oral; Asthma; Biological Availability; Bronchodilator Ag | 1982 |
Vitamin B-6 supplementation and theophylline-related effects in humans.
Topics: Adult; Alanine Transaminase; Brain; Chromatography, High Pressure Liquid; Double-Blind Method; Drug | 1994 |
Efficacy of an adenosine antagonist, theophylline, in essential tremor: comparison with placebo and propranolol.
Topics: Adenosine; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Cro | 1995 |
Controlled-release theophylline inhibits early morning airway obstruction and hyperresponsiveness in asthmatic subjects.
Topics: Administration, Inhalation; Administration, Oral; Adult; Airway Obstruction; Asthma; Circadian Rhyth | 1996 |
The effect of intravenous aminophylline on essential tremor.
Topics: Adolescent; Adult; Aged; Aminophylline; Bronchodilator Agents; Cross-Over Studies; Female; Humans; I | 1997 |
Lack of effect of dirithromycin on theophylline pharmacokinetics in healthy volunteers.
Topics: Adult; Anti-Bacterial Agents; Area Under Curve; Drug Interactions; Drug Therapy, Combination; Dyspep | 1999 |
A comparison of a theophylline-ephedrine combination with terbutaline.
Topics: Adult; Asthma; Clinical Trials as Topic; Cyclic AMP; Drug Combinations; Ephedrine; Humans; Lung; Ter | 1978 |
[The bronchospasmolytics salbutamol, fenoterol, terbutaline and reproterol. Their effects and side effects in asthmatics after inhalation with an electric nebulizer].
Topics: Adult; Aged; Albuterol; Asthma; Bronchodilator Agents; Female; Fenoterol; Humans; Hypoxia; Male; Met | 1978 |
[Comparative study of theophylline and propranolol in essential tremor].
Topics: Aged; Drug Evaluation; Female; Hand; Humans; Male; Placebos; Propranolol; Theophylline; Tremor | 1992 |
The effect of theophylline on essential tremor: the possible role of GABA.
Topics: Adenosine; Adult; Aged; Aged, 80 and over; Animals; Cerebral Cortex; Delayed-Action Preparations; Do | 1991 |
Long-term oral therapy of asthma with terbutaline and theophylline, alone and combined.
Topics: Administration, Oral; Adolescent; Adult; Aged; Akathisia, Drug-Induced; Arrhythmias, Cardiac; Asthma | 1985 |
The effect of theophylline on thyrotoxic tremor.
Topics: Aged; Female; Humans; Hyperthyroidism; Injections, Intravenous; Male; Middle Aged; Theophylline; Tre | 1989 |
Combination therapy of theophylline and terbutaline as sustained-release preparations in patients with asthmatic bronchitis.
Topics: Adult; Asthma; Cyclic AMP; Delayed-Action Preparations; Double-Blind Method; Drug Evaluation; Drug T | 1987 |
Lung function improvement, tremor measurements and c-AMP determinations in a group of ten patients with asthmatic bronchitis after one week sustained release theophylline medication (theophylline plasma level +/- 10 mg/l) compared to one week placebo.
Topics: Asthma; Bronchitis; Cyclic AMP; Delayed-Action Preparations; Female; Humans; Male; Respiratory Funct | 1986 |
10 other studies available for theophylline and Tremor
| Article | Year |
|---|---|
Differential effects of adenosine antagonists in two models of parkinsonian tremor.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Animals; Caffeine; | 2009 |
Simultaneous treatment with terbutaline and theophylline.
Topics: Adult; Aged; Asthma; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Forced | 1984 |
Separate and combined use of terbutaline and theophylline in asthmatics. Effects related to plasma levels.
Topics: Adult; Aged; Asthma; Dose-Response Relationship, Drug; Drug Interactions; Female; Forced Expiratory | 1982 |
[Effectiveness of proxyphylline in chronic obstructive pulmonary disease (author's transl)].
Topics: Adult; Aged; Aminophylline; Bronchospirometry; Humans; Lung Diseases, Obstructive; Male; Middle Aged | 1980 |
Theophylline bioavailability following oral administration of six sustained-release preparations.
Topics: Administration, Oral; Adult; Biological Availability; Delayed-Action Preparations; Drug Evaluation; | 1978 |
Choreiform movements observed in an 8-year-old child following use of an oral theophylline preparation.
Topics: Administration, Oral; Asthma; Child; Chorea; Humans; Male; Theophylline; Tremor | 1992 |
Theophylline concentrations in serum, saliva, and cerebrospinal fluid in patients with essential tremor.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Radioimmunoassay; Saliva; Theophy | 1992 |
Pharmacodynamics (lung function tests, tremor measurements and cAMP determinations) of a single dose of 0.5 mg terbutaline subcutaneously during sustained-release theophylline medication in patients with asthmatic bronchitis.
Topics: Adult; Asthma; Bronchitis; Cyclic AMP; Delayed-Action Preparations; Drug Interactions; Female; Human | 1986 |
Theophylline toxicity in children.
Topics: Abdomen; Adolescent; Child; Child, Preschool; Female; Humans; Infant; Male; Pain; Seizures; Tachycar | 1986 |
[The emetic action of theophylline in the dog].
Topics: Animals; Chlorpromazine; Dogs; Dose-Response Relationship, Drug; Emetics; Haloperidol; Myotonia; Nau | 1974 |